Plaintiff seeks to obtain a ruling on the issue of the relationship between glyphosate and the carcinogenic effects on humans. In seeking to resolve this common question in one forum, the Plaintiff expects to save millions of dollars for the class members and hundreds of thousands of hours of judicial time and resources. The case is related to: MDL No: 2471. On June 24, 2020, Bayer seeks an agreement to settle current US Roundup litigation. However, the agreement would delay any new Roundup cancer claims for years and shift the key question of whether or not the weed killer causes cancer from a jury to a hand-picked panel of scientists. On 7/6/2020, a preliminary order from Judge Chhabria states that the Court is skeptical of the propriety and fairness of the proposed settlement, and is tentatively inclined to deny the motion. On 7/8/2020, Bayer withdraws its proposal for class action settlement of future Roundup claims. On Feb. 3, 2021, Bayer announces a new $2 billion plan to resolve future Roundup cancer litigation that would compensate “qualified claimants” over a four-year program. Plaintiffs’ class counsel are filing a motion for preliminary approval of the class agreement. The plan must be approved by Judge Chhabria.